Latigo Biotherapeutics, Inc. Common Stock (LTGO) Price Prediction & Forecast

$15.540

-0.284 (-1.83%)At close

Price Predictions

1-Day Price Prediction

+0.84%

1-Week Prediction

-0.37%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

LTGO Prediction & Forecast by Similar Chart Analysis

Alphio's LTGO stock price prediction model matches the current Latigo Biotherapeutics, Inc. Common Stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.67 (+0.84%). The 1-week path is $15.48 (-0.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Latigo Biotherapeutics, Inc. Common Stock Stock?

Latigo Biotherapeutics appears to be a good buy right now, with a current price of $15.02 and a strong analyst price target of $50, suggesting a potential upside of 233%. Additionally, the company's lead asset, LTG-001, is expected to show promising results in upcoming studies, which could drive further price appreciation. However, the main risk is its negative earnings per share of -0.41, indicating ongoing financial losses that investors should monitor closely.

LTGO stock price ended at $15.54 on Thursday, after losing -1.83%

Latigo Biotherapeutics, Inc. Common Stock (LTGO) last closed at $15.54, losing -1.83%. These facts feed the 1-day and 1-week LTGO price prediction above.